Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgotinib versus placebo in adults with moderately to severely active rheumatoid arthritis with inadequate response or intolerance to biologic DMARDs
MOH_2017-07-26_000197Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of filgotinib in rheumatoid arthritis (RA) (3 arms), sponsored by Gilead Sciences. Started Dec 2016; status: completed.
02
Drugs
filgotinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on MOH_2017-07-26_000197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-07-26_000197.